Safety of Protocol Violations in Acute Stroke tPA Administration

BACKGROUND: Intravenous (IV) tissue plasminogen activator remains the only approved therapy for acute ischemic stroke (AIS) in the United States; however, less than 10% of patients receive treatment. This is partially because of the large number of contraindications, narrow treatment window, and phy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Stroke Cerebrovasc Dis
Main Authors: Lyerly, Michael J., Albright, Karen C., Boehme, Amelia K., Shahripour, Reza Bavarsad, Houston, James T., Rawal, Pawan V., Kapoor, Niren, Alvi, Muhammad, Sisson, April, Alexandrov, Anne W., Alexandrov, Andrei V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602367/
https://ncbi.nlm.nih.gov/pubmed/23954609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados